サワイグループホールディングスの株価時系列
| 日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
|---|---|---|---|---|---|---|---|
| 2023/10/03 | 4,495 | 4,517 | 4,436 | 4,464 | +65 | +1.5% | 263,200 |
| 2023/10/02 | 4,578 | 4,587 | 4,388 | 4,399 | -179 | -3.9% | 218,600 |
| 2023/09/29 | 4,621 | 4,621 | 4,511 | 4,578 | -4 | -0.1% | 271,700 |
| 2023/09/28 | 4,555 | 4,630 | 4,516 | 4,582 | -73 | -1.6% | 168,300 |
| 2023/09/27 | 4,597 | 4,655 | 4,557 | 4,655 | +58 | +1.3% | 187,800 |
| 2023/09/26 | 4,664 | 4,665 | 4,548 | 4,597 | -20 | -0.4% | 180,700 |
| 2023/09/25 | 4,591 | 4,617 | 4,532 | 4,617 | +61 | +1.3% | 155,100 |
| 2023/09/22 | 4,527 | 4,589 | 4,521 | 4,556 | -6 | -0.1% | 232,300 |
| 2023/09/21 | 4,532 | 4,609 | 4,530 | 4,562 | -3 | -0.1% | 217,900 |
| 2023/09/20 | 4,579 | 4,669 | 4,527 | 4,565 | -36 | -0.8% | 472,700 |
| 2023/09/19 | 4,587 | 4,626 | 4,533 | 4,601 | +53 | +1.2% | 285,500 |
| 2023/09/15 | 4,491 | 4,599 | 4,461 | 4,548 | +127 | +2.9% | 467,200 |
| 2023/09/14 | 4,402 | 4,431 | 4,362 | 4,421 | +28 | +0.6% | 162,700 |
| 2023/09/13 | 4,394 | 4,448 | 4,367 | 4,393 | +10 | +0.2% | 251,800 |
| 2023/09/12 | 4,333 | 4,402 | 4,318 | 4,383 | +55 | +1.3% | 171,100 |
| 2023/09/11 | 4,438 | 4,449 | 4,297 | 4,328 | -68 | -1.5% | 203,400 |
| 2023/09/08 | 4,306 | 4,402 | 4,306 | 4,396 | +63 | +1.5% | 657,300 |
| 2023/09/07 | 4,364 | 4,377 | 4,261 | 4,333 | -48 | -1.1% | 801,500 |
| 2023/09/06 | 4,360 | 4,399 | 4,256 | 4,381 | -96 | -2.1% | 1,213,500 |
| 2023/09/05 | 4,716 | 4,716 | 4,435 | 4,477 | -239 | -5.1% | 1,164,400 |
| 2023/09/04 | 4,729 | 4,730 | 4,680 | 4,716 | -6 | -0.1% | 405,600 |
| 2023/09/01 | 4,685 | 4,727 | 4,636 | 4,722 | +44 | +0.9% | 305,800 |
| 2023/08/31 | 4,665 | 4,729 | 4,631 | 4,678 | +133 | +2.9% | 573,500 |
| 2023/08/30 | 4,476 | 4,563 | 4,431 | 4,545 | +17 | +0.4% | 214,300 |
| 2023/08/29 | 4,450 | 4,600 | 4,447 | 4,528 | +90 | +2% | 316,300 |
| 2023/08/28 | 4,440 | 4,451 | 4,383 | 4,438 | +20 | +0.5% | 169,400 |
| 2023/08/25 | 4,473 | 4,474 | 4,397 | 4,418 | -60 | -1.3% | 209,800 |
| 2023/08/24 | 4,429 | 4,481 | 4,386 | 4,478 | +38 | +0.9% | 309,300 |
| 2023/08/23 | 4,412 | 4,441 | 4,337 | 4,440 | +20 | +0.5% | 483,500 |
| 2023/08/22 | 4,453 | 4,503 | 4,371 | 4,420 | +271 | +6.5% | 652,200 |
| 2023/08/21 | 4,078 | 4,221 | 4,070 | 4,149 | +1 | ±0% | 418,500 |
| 2023/08/18 | 4,008 | 4,252 | 3,986 | 4,148 | +117 | +2.9% | 821,900 |
| 2023/08/17 | 3,892 | 4,039 | 3,853 | 4,031 | +149 | +3.8% | 731,000 |
| 2023/08/16 | 3,735 | 3,896 | 3,708 | 3,882 | +137 | +3.7% | 465,600 |
| 2023/08/15 | 3,676 | 3,754 | 3,643 | 3,745 | +90 | +2.5% | 378,100 |
| 2023/08/14 | 3,715 | 3,728 | 3,607 | 3,655 | -60 | -1.6% | 284,300 |
| 2023/08/10 | 3,555 | 3,716 | 3,537 | 3,715 | +196 | +5.6% | 574,600 |
| 2023/08/09 | 3,528 | 3,547 | 3,373 | 3,519 | -13 | -0.4% | 482,800 |
| 2023/08/08 | 3,517 | 3,550 | 3,507 | 3,532 | ±0 | ±0% | 298,700 |
| 2023/08/07 | 3,500 | 3,554 | 3,484 | 3,532 | +26 | +0.7% | 199,700 |
| 2023/08/04 | 3,495 | 3,509 | 3,473 | 3,506 | +11 | +0.3% | 177,100 |
| 2023/08/03 | 3,533 | 3,540 | 3,486 | 3,495 | -54 | -1.5% | 299,500 |
| 2023/08/02 | 3,554 | 3,578 | 3,536 | 3,549 | -26 | -0.7% | 227,500 |
| 2023/08/01 | 3,580 | 3,595 | 3,564 | 3,575 | +30 | +0.8% | 138,300 |
| 2023/07/31 | 3,582 | 3,585 | 3,540 | 3,545 | +18 | +0.5% | 111,500 |
| 2023/07/28 | 3,510 | 3,536 | 3,494 | 3,527 | -33 | -0.9% | 196,400 |
| 2023/07/27 | 3,565 | 3,565 | 3,510 | 3,560 | -6 | -0.2% | 130,100 |
| 2023/07/26 | 3,535 | 3,566 | 3,511 | 3,566 | +22 | +0.6% | 119,100 |
| 2023/07/25 | 3,532 | 3,546 | 3,504 | 3,544 | +12 | +0.3% | 143,500 |
| 2023/07/24 | 3,494 | 3,535 | 3,476 | 3,532 | +71 | +2.1% | 129,800 |
151～
200
件表示中 / 765件
類似銘柄と比較する
現在ご覧いただいている「サワイＧＨＤ」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
| 銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
|---|---|---|---|---|---|---|---|---|
| サワイＧＨＤ | 612,300円 | +14.2% | +48.9% | 2.60% | 8.94倍 | 1.27倍 |
|
ジェネリック（後発）薬大手メーカー。２１年春に沢井製薬が持株会社化。大型買収で米国本格展開 |
| 久光薬 | 380,500円 | +7.3% | -3.8% | 2.37% | 18.24倍 | 1.09倍 |
|
貼る鎮痛消炎剤首位。医療用シェア５割。大衆薬「サロンパス」で有名。米国、中国など海外強化 |
| ツムラ | 398,300円 | +22.6% | +68.1% | 3.41% | 10.62倍 | 1.12倍 |
|
医療用漢方薬で国内シェア８割超。高齢者、がん支持療法、女性関連の３領域を重点に市場深耕 |
| 日本新薬 | 369,700円 | +1.2% | -6.3% | 3.35% | 10.17倍 | 1.13倍 |
|
医家向け医薬品主体、自社創薬は泌尿器科、血液内科、難病・希少疾患に集中。機能食品も育成 |
| ペプチド | 191,200円 | +56.7% | +357.2% | 0.00% | 17.70倍 | 6.14倍 |
|
東大発のペプチド創薬ベンチャーの雄。海外製薬大手との提携多数。買収で放射性医薬品に参入 |
市場注目の銘柄
チャート関連のコラム
